Firefly Neuroscience to Participate in the 8th Annual Florida Capital Event
Firefly Neuroscience (NASDAQ: AIFF), an AI company focused on brain health solutions, has announced its participation in the Capital Event Management Conference. The event will take place at the JW Marriott Miami in Aventura, Florida from November 22-24, 2024. The company, which develops innovative solutions for patients with neurological and mental disorders, is offering one-on-one investor meetings during the conference. Interested parties can schedule meetings through CEM representatives or by contacting KCSA Strategic Communications.
Firefly Neuroscience (NASDAQ: AIFF), un'azienda di intelligenza artificiale focalizzata sulle soluzioni per la salute cerebrale, ha annunciato la sua partecipazione al Capital Event Management Conference. L'evento si svolgerà presso il JW Marriott Miami ad Aventura, Florida, dal 22 al 24 novembre 2024. L'azienda, che sviluppa soluzioni innovative per pazienti con disturbi neurologici e mentali, offre incontri individuali con gli investitori durante la conferenza. Le parti interessate possono programmare gli incontri tramite i rappresentanti di CEM o contattando KCSA Strategic Communications.
Firefly Neuroscience (NASDAQ: AIFF), una empresa de inteligencia artificial centrada en soluciones para la salud cerebral, ha anunciado su participación en la Capital Event Management Conference. El evento se llevará a cabo en el JW Marriott Miami en Aventura, Florida, del 22 al 24 de noviembre de 2024. La compañía, que desarrolla soluciones innovadoras para pacientes con trastornos neurológicos y mentales, ofrecerá reuniones one-on-one con inversores durante la conferencia. Las partes interesadas pueden programar reuniones a través de los representantes de CEM o contactando a KCSA Strategic Communications.
파이어플라이 뉴로사이언스 (NASDAQ: AIFF), 뇌 건강 솔루션에 중점을 둔 AI 회사가 자본 이벤트 관리 회의에 참여한다고 발표했습니다. 이 행사는 2024년 11월 22일부터 24일까지 플로리다 애벤투라에 있는 JW 메리어트 마이애미에서 열립니다. 신경 및 정신 장애를 가진 환자를 위한 혁신적인 솔루션을 개발하는 이 회사는 회의 동안 투자자와의 개별 미팅을 제공합니다. 관심 있는 분들은 CEM 대표를 통해 미팅을 예약하거나 KCSA 전략 커뮤니케이션에 연락할 수 있습니다.
Firefly Neuroscience (NASDAQ: AIFF), une entreprise d'IA axée sur des solutions pour la santé cérébrale, a annoncé sa participation à la Capital Event Management Conference. L'événement se déroulera au JW Marriott Miami à Aventura, en Floride, du 22 au 24 novembre 2024. L'entreprise, qui développe des solutions innovantes pour les patients souffrant de troubles neurologiques et mentaux, propose des réunions individuelles avec des investisseurs durant la conférence. Les parties intéressées peuvent programmer des réunions via les représentants de CEM ou en contactant KCSA Strategic Communications.
Firefly Neuroscience (NASDAQ: AIFF), ein KI-Unternehmen, das sich auf Lösungen für die Gehirngesundheit konzentriert, hat seine Teilnahme an der Capital Event Management Conference bekannt gegeben. Die Veranstaltung findet vom 22. bis 24. November 2024 im JW Marriott Miami in Aventura, Florida, statt. Das Unternehmen, das innovative Lösungen für Patienten mit neurologischen und psychischen Störungen entwickelt, bietet während der Konferenz Einzelgespräche mit Investoren an. Interessierte Parteien können Meetings über die Vertreter von CEM planen oder KCSA Strategic Communications kontaktieren.
- None.
- None.
TORONTO, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced that management will participate in the Capital Event Management Conference being held at the JW Marriott Miami in Aventura, Florida on November 22-24, 2024.
To schedule a one-on-one investor meeting with management, please contact your representatives at CEM or email KCSA Strategic Communications at Firefly@KCSA.com.
About CEM
CEM curates exclusive live events and virtual meetings where issuers and investors have unique opportunities to connect 1:1 and build lasting relationships. Since 2011 CEM has provided issuers a forum to raise capital, gain market support, save time & money, and build relationships with leading North American small cap investors.
About Firefly
Firefly (NASDAQ: AIFF) is an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders. Firefly’s FDA-510(k) cleared Brain Network Analytics (BNA™) technology revolutionizes diagnostic and treatment monitoring methods for conditions such as depression, dementia, anxiety disorders, concussions, and ADHD. Over the past 15 years, Firefly has built a comprehensive database of brain wave tests, securing patent protection, and achieving FDA clearance. The Company is now launching BNA™ commercially, targeting pharmaceutical companies engaged in drug research and clinical trials, as well as medical practitioners for clinical use.
Brain Network Analytics was developed using artificial intelligence and machine learning on Firefly’s extensive proprietary database of standardized, high-definition longitudinal electroencephalograms (EEGs) of over 17,000 patients representing twelve disorders, as well as clinically normal patients. BNA™, in conjunction with an FDA-cleared EEG system, can provide clinicians with comprehensive insights into brain function. These insights can enhance a clinician’s ability to accurately diagnose mental and cognitive disorders and to evaluate what therapy and/or drug is best suited to optimize a patient’s outcome.
Please visit https://fireflyneuro.com/ for more information.
Investor Contact
KCSA Strategic Communications
Valter Pinto or Jack Perkins
(212) 896-1254
Firefly@KCSA.com
Media Contact
KCSA Strategic Communications
Raquel Cona, Vice President
(516) 779-2630
Rcona@KCSA.com
FAQ
When is Firefly Neuroscience (AIFF) participating in the Florida Capital Event?
How can investors schedule meetings with Firefly Neuroscience (AIFF) at the Florida Capital Event?
What is the focus of Firefly Neuroscience's (AIFF) business?
